The paper's citation list

No.
The paper's citation list
1
Screening high risk populations for cancer: Hepatobiliary. 2019;120:847 doi: 10.1002/jso.25633
2
Intrahepatic cholangiocarcinoma in a non-cirrhotic liver in a patient with homozygous ZZ alpha-1 antitrypsin deficiency. 2021;14:e240077 doi: 10.1136/bcr-2020-240077
3
Genomic and Transcriptomic Landscape of Tumor Clonal Evolution in Cholangiocarcinoma. 2020;11: doi: 10.3389/fgene.2020.00195
4
Mechanisms and Therapy of Liver Cancer. 2021;149:321 doi: 10.1016/bs.acr.2020.10.005
5
Current interventional options for palliative care for patients with advanced-stage cholangiocarcinoma. 2024;15:381 doi: 10.5306/wjco.v15.i3.381
6
Cost-effectiveness of pemigatinib as a second-line treatment for advanced intrahepatic cholangiocarcinoma with fibroblast growth factor receptor 2 fusions in Taiwan: from the evidence of the phase II trial and the perspective of Taiwan's National Health Insurance Administration. 2023;21: doi: 10.1186/s12962-023-00473-5
7
Artificial intelligence using advanced imaging techniques and cholangiocarcinoma: Recent advances and future direction. 2022;3:88 doi: 10.35712/aig.v3.i3.88
8
Challenges in Diagnosing and Reporting Cholangiocarcinoma. 2023;16:599 doi: 10.1016/j.path.2023.04.012
9
Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade. 2019;7: doi: 10.1186/s40425-019-0596-y
10
Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy. 2023;41:307 doi: 10.1007/s40273-022-01227-6
11
Synchronous solid pseudopapillary neoplasm of the pancreas with intrahepatic cholangiocarcinoma in a young male patient: An unusual deadly occurrence. 2021;82:105841 doi: 10.1016/j.ijscr.2021.105841
12
Hepatobiliary Cancers: Translational Advances and Molecular Medicine. 2022;156:283 doi: 10.1016/bs.acr.2022.02.003
13
Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern. 2022;16:613 doi: 10.5009/gnl210174
14
Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients. 2022;126:31 doi: 10.1016/j.humpath.2022.05.008
15
Incidental detection of intrahepatic cholangiocarcinoma in an explant liver: An unforeseen encounter. 2024;11:183 doi: 10.18231/j.ijpo.2024.039
16
Transcriptional repression and apoptosis influence the effect of APOBEC3A/3B functional polymorphisms on biliary tract cancer risk. 2022;150:1825 doi: 10.1002/ijc.33930
17
Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024;291 doi: 10.1002/9781119756422.ch17
18
Immediate results of biliodigestive reconstruction in patients with peripheral cholangiocarcinoma with invasion of visceral veins. 2024;90:2 doi: 10.26779/2786-832X.2023.5.02
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/